517
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Update on Immunological Test (Quantiferon-TB Gold) Contribution in the Management of Tuberculosis-Related Ocular Inflammation

, MD, PhD, , MD, PhD & , MD, PhD
Pages 1192-1199 | Received 05 Feb 2017, Accepted 15 May 2017, Published online: 12 Jul 2017

References

  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis–an update. Surv Ophthalmol. 2007;52:561–587.
  • Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149:562–570.
  • Cordero-Coma M, Calleja S, Torres HE, et al. The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitis revisited: Utility of the new IGRAs. Eye (Lond). 2010;24:36–43.
  • Gupta A, Sharma A, Bansal R, et al. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23:7–13.
  • Bajgai P, Sharma K, Bansal R, et al. Detection of mycobacterium tuberculosis genome in subretinal fluid of patients with latent tuberculosis infection. Ocul Immunol Inflamm. 2016 Dec;24(6):615–620.
  • Gineys R, Bodaghi B, Carcelain G, et al. QuantiFERON-TB gold cut-off value: Implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol. 2011;152:433–440.
  • Bansal R, Gupta A, Gupta V, et al. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology. 2012;119:2334–2342.
  • Babu K, Bhat SS, Philips M, et al. Review of results of QuantiFERON TB gold test in presumed ocular tuberculosis in a South Indian patient population. Ocul Immunol Inflamm. 2016 Oct;24(5):498–502.
  • Agrawal R, Gupta B, Gonzalez-Lopez JJ, et al. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm. 2015;23:40–46.
  • Babu K, Satish V, Satish S, et al. Utility of QuantiFERON TB gold test in a south Indian patient population of ocular inflammation. Indian J Ophthalmol. 2009;57:427–430.
  • Bansal R, Gupta A, Gupta V, et al. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008;146:772–779.
  • Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm. 2009;17:351–355.
  • Nazari H, Karakousis PC, Rao NA. Replication of mycobacterium tuberculosis in retinal pigment epithelium. JAMA Ophthalmol. 2014;132:724–729.
  • Demirci H, Shields CL, Shields JA, et al. Ocular tuberculosis masquerading as ocular tumors. Surv Ophthalmol. 2004;49:78–89.
  • Venkatesh P, Gogia V, Shah B, et al. Patterns of uveitis at the Apex Institute for Eye Care in India: Results from a prospectively enrolled patient data base (2011-2013). Int Ophthalmol. 2016;36:365–372.
  • Heiden D, Saranchuk P, Keenan JD, et al. Eye examination for early diagnosis of disseminated tuberculosis in patients with AIDS. Lancet Infect Dis. 2016;16:493–499.
  • Menzies D, Pai M, Comstock G. Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340–354.
  • Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: Clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116:1391–1396.
  • Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology. 2002;109:851–857.
  • Cimino L, Herbort CP, Aldigeri R, et al. Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol. 2009;29:67–74.
  • Hong BK, Khanamiri HN, Bababeygy SR, et al. The utility of routine tuberculosis screening in county hospital patients with uveitis. Br J Ophthalmol. 2014;98:1091–1095.
  • Fd Nienhaus A, Schablon A, Costa JT, et al. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res. 2011 Sep;30(11):247.
  • Ang M, Nguyen HV, Kiew SY, et al. Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis. Br J Ophthalmol. 2015;99:984–989.
  • Urzua CA, Liberman P, Abuauad S, et al. Evaluation of the accuracy of T-SPOT.TB for the diagnosis of ocular tuberculosis in a BCG-vaccinated, non-endemic population. Ocul Immunol Inflamm. 2016;4:1–5.
  • Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis. 2007;44:69–73.
  • Ang M, Wanling W, Chee SP. Clinical significance of an equivocal interferon γ release assay result. Br J Ophthalmol. 2012;96:284–288.
  • Agrawal R, Gonzalez-Lopez JJ, Nobre-Cardoso J, et al. Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence. Br J Ophthalmol. 2016;100:348–355.
  • Weddle G, Hamilton M, Potthoff D, et al. QuantiFERON-TB Gold in-tube testing for tuberculosis in healthcare professionals. Lab Med. 2014;45:207–210.
  • Sudharshan S, Ganesh SK, Balu G, et al. Utility of QuantiFERON®-TB gold test in diagnosis and management of suspected tubercular uveitis in India. Int Ophthalmol. 2012;32:217–223.
  • Ang M, Wong W, Ngan CC, et al. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye (Lond). 2012;26:658–665.
  • Ang M, Kiew SY, Wong WL, et al. Discordance of two interferon-γ release assays and tuberculin skin test in patients with uveitis. Br J Ophthalmol. 2014;98:1649–1653.
  • Mackensen F, Becker MD, Wiehler U, et al. QuantiFERON TB-gold–a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis. Am J Ophthalmol. 2008;146:761–766.
  • Itty S, Bakri SJ, Pulido JS, et al. Initial results of QuantiFERON-TB gold testing in patients with uveitis. Eye (Lond). 2009;23:904–909.
  • La Distia Nora R, Van Velthoven ME, Ten Dam-Van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157:754–761.
  • Jakob E, Max R, Zimmermann S, et al. Three years of experience with QuantiFERON-TB gold testing in patients with uveitis. Ocul Immunol Inflamm. 2014;22:478–484.
  • Albini TA, Karakousis PC, Rao NA. Interferon-gamma release assays in the diagnosis of tuberculous uveitis. Am J Ophthalmol. 2008;146:486–488.
  • Caspers L, Makhoul D, Ebraert H, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;158:646–647.
  • Pepple KL, Van Gelder R, Forooghian F. Caveats about QuantiFERON-TB gold in-tube testing for uveitis. Am J Ophthalmol. 2014;157:752–753.
  • González-López JJ, Ám G-A, Sánchez-Ponce D, et al. Development and validation of a Bayesian network for the differential diagnosis of anterior uveitis. Eye (Lond). 2016;30:865–872.
  • Lou SM, Larkin KL, Winthrop K, et al. Uveitis Specialists Study Group. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. Ocul Immunol Inflamm. 2015;23:25–31.
  • Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23:14–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.